197 related articles for article (PubMed ID: 21422428)
1. Circulating tumor cells: not all detected cells are bad and not all bad cells are detected.
Wicha MS; Hayes DF
J Clin Oncol; 2011 Apr; 29(12):1508-11. PubMed ID: 21422428
[No Abstract] [Full Text] [Related]
2. Evaluation and prognostic significance of circulating tumor cells in patients with non-small-cell lung cancer.
Krebs MG; Sloane R; Priest L; Lancashire L; Hou JM; Greystoke A; Ward TH; Ferraldeschi R; Hughes A; Clack G; Ranson M; Dive C; Blackhall FH
J Clin Oncol; 2011 Apr; 29(12):1556-63. PubMed ID: 21422424
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant chemotherapy for non-small-cell lung cancer: a fading effect?
Besse B; Le Chevalier T
J Clin Oncol; 2008 Nov; 26(31):5014-7. PubMed ID: 18809602
[No Abstract] [Full Text] [Related]
4. Identifying circulating tumor stem cells that matter: the key to prognostication and therapeutic targeting.
Faltas B; Zeidan A; Peters K; Das A; Joudeh J; Navaraj A; Dolloff NG; Harvey HA; Jiang Y; Allen JE; Dicker DT; El Deiry WS
J Clin Oncol; 2011 Jul; 29(21):2946-7; author reply 2947-8. PubMed ID: 21690466
[No Abstract] [Full Text] [Related]
5. Preoperative circulating tumor cell detection using the isolation by size of epithelial tumor cell method for patients with lung cancer is a new prognostic biomarker.
Hofman V; Bonnetaud C; Ilie MI; Vielh P; Vignaud JM; Fléjou JF; Lantuejoul S; Piaton E; Mourad N; Butori C; Selva E; Poudenx M; Sibon S; Kelhef S; Vénissac N; Jais JP; Mouroux J; Molina TJ; Hofman P
Clin Cancer Res; 2011 Feb; 17(4):827-35. PubMed ID: 21098695
[TBL] [Abstract][Full Text] [Related]
6. Identification of immunohistochemical prognostic markers for survival after resection of pulmonary metastases from colorectal carcinoma.
Pfannschmidt J; Bade S; Hoheisel J; Muley T; Dienemann H; Herpel E
Thorac Cardiovasc Surg; 2009 Oct; 57(7):403-8. PubMed ID: 19795327
[TBL] [Abstract][Full Text] [Related]
7. [Bone marrow isolated micrometastases of non-small cell lung cancer].
Dancewicz M; Kowalewski J; Sir J; Pepliński J; Jezierska A
Pol Merkur Lekarski; 2006 Mar; 20(117):315-7. PubMed ID: 16780264
[TBL] [Abstract][Full Text] [Related]
8. Invited commentary.
Fieguth HG
Ann Thorac Surg; 2005 Sep; 80(3):1026-7. PubMed ID: 16122478
[No Abstract] [Full Text] [Related]
9. Mortality associated with pneumonectomy after induction chemoradiation versus chemotherapy alone in stage IIIA-N2 non-small cell lung cancer.
Van Schil PE
J Thorac Cardiovasc Surg; 2008 Mar; 135(3):718; author reply 718-9. PubMed ID: 18329516
[No Abstract] [Full Text] [Related]
10. Pemetrexed pathway-associated germline polymorphisms: a useful tool for treatment individualization?
Buikhuisen WA; Burgers JA; Vincent AD; Schellens JH; Beijnen JH; Smit EF; Joerger M
J Clin Oncol; 2010 Sep; 28(27):e482-3; author reply e484. PubMed ID: 20606096
[No Abstract] [Full Text] [Related]
11. [The role of tumor markers in the pre-therapeutic staging of non-small cell bronchial cancer].
Biron P
Rev Mal Respir; 1992; 9 Suppl 4():R299-304. PubMed ID: 1336877
[TBL] [Abstract][Full Text] [Related]
12. Cluster analysis of p-glycoprotein, c-erb-B2 and P53 in relation to tumor histology strongly indicates prognosis in patients with operable non-small cell lung cancer.
Bozcuk H; Gumus A; Ozbilim G; Sarper A; Kucukosmanoglu I; Ozbudak IH; Artac M; Ozdogan M; Samur M; Kaya A; Savas B
Med Sci Monit; 2005 Jun; 11(6):HY11-20. PubMed ID: 15917726
[TBL] [Abstract][Full Text] [Related]
13. Lack of prognostic influence of circulating tumor cells in peripheral blood of patients with colorectal cancer.
Bessa X; Elizalde JI; Boix L; Piñol V; Lacy AM; Saló J; Piqué JM; Castells A
Gastroenterology; 2001 Apr; 120(5):1084-92. PubMed ID: 11266372
[TBL] [Abstract][Full Text] [Related]
14. Artificial neural networks and logistic regression as tools for prediction of survival in patients with Stages I and II non-small cell lung cancer.
Marchevsky AM; Patel S; Wiley KJ; Stephenson MA; Gondo M; Brown RW; Yi ES; Benedict WF; Anton RC; Cagle PT
Mod Pathol; 1998 Jul; 11(7):618-25. PubMed ID: 9688182
[TBL] [Abstract][Full Text] [Related]
15. Survival of patients with clinical stage IIIA non-small cell lung cancer after induction therapy: age, mediastinal downstaging, and extent of pulmonary resection as independent predictors.
Paul S; Mirza F; Port JL; Lee PC; Stiles BM; Kansler AL; Altorki NK
J Thorac Cardiovasc Surg; 2011 Jan; 141(1):48-58. PubMed ID: 21092990
[TBL] [Abstract][Full Text] [Related]
16. What is the optimal treatment of stage IIIA-N2 non-small-cell lung cancer after EORTC 08941?
Van Meerbeeck JP; De Pauw R; Tournoy K
Expert Rev Anticancer Ther; 2008 Feb; 8(2):199-206. PubMed ID: 18279061
[TBL] [Abstract][Full Text] [Related]
17. eComment: Octogenarians: do we have to consider new age specific parameters in our practice?
Paliouras D; Klimatsidas M; Samanidis G; Daliakopoulos S
Interact Cardiovasc Thorac Surg; 2011 May; 12(5):753. PubMed ID: 21555440
[No Abstract] [Full Text] [Related]
18. Predictive and prognostic value of circulating tumor cell detection in lung cancer: a clinician's perspective.
Tognela A; Spring KJ; Becker T; Caixeiro NJ; Bray VJ; Yip PY; Chua W; Lim SH; de Souza P
Crit Rev Oncol Hematol; 2015 Feb; 93(2):90-102. PubMed ID: 25459665
[TBL] [Abstract][Full Text] [Related]
19. Detection of disseminated lung cancer cells in lymph nodes: impact on staging and prognosis.
Passlick B; Izbicki JR; Kubuschok B; Thetter O; Pantel K
Ann Thorac Surg; 1996 Jan; 61(1):177-82; discussion 183. PubMed ID: 8561549
[TBL] [Abstract][Full Text] [Related]
20. A new tumor suppressor DnaJ-like heat shock protein, HLJ1, and survival of patients with non-small-cell lung carcinoma.
Tsai MF; Wang CC; Chang GC; Chen CY; Chen HY; Cheng CL; Yang YP; Wu CY; Shih FY; Liu CC; Lin HP; Jou YS; Lin SC; Lin CW; Chen WJ; Chan WK; Chen JJ; Yang PC
J Natl Cancer Inst; 2006 Jun; 98(12):825-38. PubMed ID: 16788156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
